Table 2.
In-hospital events and treatment strategy in Takotsubo syndrome (TTS) and acute coronary syndrome (ACS) patients both treated with ß-antagonists.
| Variables | TTS (n=103) |
ACS (n=422) |
p value* |
|---|---|---|---|
| Life-threatening arrhythmia | 8 (7.8) | 29 (6.9) | 0.74 |
| NPPV and or intubation | 53 (51.5) | 16 (3.8) | <0.01 |
| Inotropic agents | 11 (10.7) | 14 (3.3) | <0.01 |
| Resuscitation | 4 (3.9) | 15 (3.6) | 0.87 |
| Device-Implantation | 3 (2.9) | 39 (9.2) | 0.03 |
| Admission to ICU. length of stay (IQR) | 5 (0-52) | 3 (0-20) | <0.01 |
| In-hospital death | 0 (0.0) | 1 (0.2) | 0.62 |
| Thromboembolic events | 15 (14.6) | 9 (2.1) | <0.01 |
| Cardiogenic Shock | 12 (11.9) | 15 (3.6) | <0.01 |
*p values for the comparison between TTS and ACS; NPPV. Noninvasive positive pressure ventilation; ICU, Intermediate care unit.